We’ll now we know why with the pay cut and issue of options. Never found this mob to be a leaky ship, outside of there circle anyway, that being said I believe Ance will win through in the long run, Psoriasis and Rosacea are a good chance if they fall about 60% mark between Ance and AD, as for Antibacterial I reckon we’re a good chance and that will be huge and bring the others with us. Management have had there fill, no more for them and there mates. Time to come through with no more concessions
Ann: FDA Grants BTX 1801 QIDP Designation Status, page-60
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.050(14.3%) |
Mkt cap ! $724.0M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 40.0¢ | 35.5¢ | $6.075M | 15.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 287187 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 1920397 | 33 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |